logotype
Sign inJoin Now

ASX 200 adds 0.3%; CSL falls on $760m biotech deal

Oliver Gray

Oliver Gray

Editor and Financial Journalist

ASX 200 adds 0.3%; CSL falls on $760m biotech deal
Credit: Martin David / Unsplash